v3.26.1
Stock-Based Compensation (Tables)
 12 Months Ended
Jul. 03, 2026
Share-Based Payment Arrangement [Abstract]  
Summary of Nonvested Restricted Stock
The following table summarizes the status of the Company’s non-vested restricted stock awards and deferred stock awards since June 28, 2024:
Non-Vested Restricted Stock Awards
Number of
Shares		Weighted Average
Grant Date
Fair Value
Outstanding at June 28, 20241,526 $41.35 
Granted939 41.47 
Vested(409)44.69 
Forfeited(314)41.40 
Outstanding at June 27, 20251,742 $40.37 
Granted573 69.40 
Vested(495)41.14 
Forfeited(148)48.23 
Outstanding at July 3, 20261,672 $45.50 
Stock Based Compensation Expenses
The following table presents share-based compensation expenses from continuing operations included in the Company’s Consolidated Statements of Operations and Comprehensive Loss:
Fiscal Years Ended
July 3, 2026June 27, 2025June 28, 2024
Cost of revenues$5,584 $1,205 $2,919 
Selling, general and administrative29,197 17,809 16,936 
Research and development6,351 6,005 5,814 
Stock-based compensation expense before tax41,132 25,019 25,669 
Income taxes(1)
(11,106)(6,755)(6,931)
Stock-based compensation expense, net of income taxes$30,026 $18,264 $18,738 
(1) Federal and state statutory rate of 27%
Summary of Stock Option Plans
The following table summarizes activity with respect to Company-issued stock options since June 28, 2024:
Options Outstanding
Number of
Shares		Weighted 
Average
Grant Date
Fair Value		Weighted 
Average
Exercise Price		Weighted 
Average
Remaining
Contractual 
Term (Years)		Aggregate
Intrinsic Value as of 6/28/2024
Outstanding at June 28, 2024934 12.71 $45.00 3.69 years— 
Granted— $— 
Exercised— $— 
Cancelled— $— 
Outstanding at June 27, 2025934 $12.71 $45.00 2.75 years$— 
Granted— $— 
Exercised— $— 
Cancelled— $— 
Outstanding at July 3, 2026934 $12.71 $45.00 2.04 years$— 
Exercisable at July 3, 2026— $— $— — $—